Clinical Trials · NCT06193616
Outcome of ADPKD With Octreotide LAR
- Phase
- N/A
- Recruitment status
- Active Not Recruiting
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Enrollment
- 70
- Start date
- Feb 2024
- Locations
- 1 site, Italy
- Primary endpoint
- GFR change over time